Review: could Temozolomide cause Short-term memory loss (Memory loss)?
Summary: Short-term memory loss is found among people who take Temozolomide, especially for people who are female, 50-59 old, have been taking the drug for < 1 month, also take medication Dilantin, and have Glioblastoma multiforme.
We study 2,791 people who have side effects while taking Temozolomide from FDA and social media. Among them, 28 have Short-term memory loss. Find out below who they are, when they have Short-term memory loss and more.
You are not alone: join a support group for people who take Temozolomide and have Short-term memory loss >>>
Temozolomide has active ingredients of temozolomide. It is often used in glioblastoma multiforme. (latest outcomes from 2,806 Temozolomide users)
Short-term memory loss
Short-term memory loss has been reported by people with multiple sclerosis, depression, pain, high blood pressure, high blood cholesterol. (latest reports from 63,451 Short-term memory loss patients)
On Mar, 30, 2015: 2,791 people reported to have side effects when taking Temozolomide. Among them, 28 people (1.00%) have Short-term Memory Loss.
Time on Temozolomide when people have Short-term memory loss * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Short-term memory loss||66.67%||11.11%||22.22%||0.00%||0.00%||0.00%||0.00% |
Gender of people who have Short-term memory loss when taking Temozolomide * :
|Short-term memory loss||56.67%||43.33% |
Age of people who have Short-term memory loss when taking Temozolomide * :
|Short-term memory loss||0.00%||0.00%||0.00%||0.00%||0.00%||9.52%||47.62%||42.86% |
Severity of Short-term memory loss when taking Temozolomide ** :
How people recovered from Short-term memory loss ** :
Top conditions involved for these people * :
- Glioblastoma multiforme (8 people, 28.57%)
- Glioblastoma (4 people, 14.29%)
- Ependymoma (2 people, 7.14%)
- Blood corticotrophin increased (2 people, 7.14%)
- Small cell carcinoma (2 people, 7.14%)
Top co-used drugs for these people * :
- Dilantin (5 people, 17.86%)
- Decadron (5 people, 17.86%)
- Nexium (4 people, 14.29%)
- Tylenol (3 people, 10.71%)
- Neurontin (3 people, 10.71%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of Temozolomide and short-term memory loss on
Do you have Short-term Memory Loss while taking Temozolomide?
You are not alone! Join a support group on :
- support group for people who take Temozolomide and have Short-term Memory Loss
- support group for people who take Temozolomide
- support group for people who have Short-term Memory Loss
Drugs in real world that are associated with:
Could your condition cause:
- A study of side effects of Xarelto for a 89-year old man with Atrial Fibrillation. The patient has Short-term Memory Loss
- A study of drug interactions between Nuvaring, Tramadol for a 36-year old woman with Birth Control, Pain. The patient has Weight Gain, Fatigue, Forgetfulness
- A study of drug interactions between Vitamin D, Vitamin B, Paracetamol, Levothyroxine Sodium for a 95-year old woman with Osteoporosis, Lack Of Energy, Pain, Hypothyroidism. The patient has Memory Loss, Confusion
- A study of drug interactions between Fentanyl-25, Percocet, Klonopin, Depakote Er, Vimpat for a 52-year old woman with Pain, Epilepsy. The patient has Memory Loss
- A study of side effects of Cymbalta for a 64-year old woman with Depression. The patient has Memory Impairment
Recent Temozolomide related drug comparison:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.